Program Official
Principal Investigator
Vincent P
Vinciguerra
Awardee Organization
Feinstein Institute For Medical Research
United States
Fiscal Year
2024
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date
NIH RePORTER
For more information, see NIH RePORTER Project 3UG1CA189850-11S1
Northwell Health NCORP
With 35 years expertise providing vital cancer research, the Northwell Health Cancer Institute is applying to continue as a community site for the National Cancer Institute Community Oncology Research Program (NCORP). Cancer has been identified as a high priority in our catchment area and, through affiliations with the various NCORP Research bases, our site is able to bring cancer clinical research to the populations in our community. In alignment with NCORP goals, the Northwell Health NCORP will continue to: 1. provide patients access to national cancer control, prevention, treatment, and care delivery studies, 2. engage with underrepresented populations to reduce health disparities and increase health equity, and 3. identify significant concerns raised by our unique local populations. As the program continues, our community site will enhance relationships with all Northwell Health Divisions and strengthen communication between primary and subaffiliate sites. The Northwell Health Cancer Institute, including 9 NCORP performance site, is a multi-faceted program which treats approximately 14,000 patients with cancer annually. Since the inception of the new NCORP in 2014, over 300 patient have been accrued to NCI sponsored trials adding to the broad evidence base which contributed to improved patient outcomes.
Publications
- King DA, Chi J, Goyal SP, Saif MW. COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer. Archives of pharmacology and therapeutics. 2021;3(1):5-9. PMID: 34355214
- Ozga M, Nicolet D, Mrózek K, Walker CJ, Blachly JS, Kohlschmidt J, Orwick S, Carroll AJ, Larson RA, Kolitz JE, Powell BL, Stone RM, Byrd JC, Eisfeld AK, Mims AS. White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years. American journal of hematology. 2024 Nov;99(11):2236-2240. Epub 2024 Sep 16. PMID: 39283025
- Walker AR, Marcucci G, Yin J, Blum W, Stock W, Kohlschmidt J, Mrózek K, Carroll AJ, Eisfeld AK, Wang ES, Jacobson S, Kolitz JE, Thakuri M, Sutamtewagul G, Vij R, Stuart RK, Byrd JC, Bloomfield CD, Stone RM, Larson RA. Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance). Blood advances. 2021 Jul 13;5(13):2775-2787. PMID: 34251414
- Fu H, Nicolet D, Mrózek K, Stone RM, Eisfeld AK, Byrd JC, Archer KJ. Controlled variable selection in Weibull mixture cure models for high-dimensional data. Statistics in medicine. 2022 Sep 30;41(22):4340-4366. Epub 2022 Jul 6. PMID: 35792553
- Saif MW, Smith MH, Goodman MD, Salem RR. Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9? JOP : Journal of the pancreas. 2020 Aug;21(5):74-80. Epub 2020 Aug 31. PMID: 32982620
- Ehrlich MI, Saif MW. Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic? Archives of cancer biology and therapy. 2020;1(1):22-24. PMID: 32728674
- Kaplan LD, Maurer MJ, Stock W, Bartlett NL, Fulton N, Pettinger A, Byrd JC, Blum KA, LaCasce AS, Hsi ED, Liu YT, Scott DW, Hurd D, Ruppert AS, Hernandez-Ilizaliturri F, Leonard JP, Cheson BD. Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403. American journal of hematology. 2020 Jun;95(6):583-593. Epub 2020 Apr 6. PMID: 32170769
- Saif MW. New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020. JOP : Journal of the pancreas. 2020 Aug;21(5):108-111. PMID: 32905526
- Ehrlich MI, Saif MW. Potential Impact of Delay in Cancer Screening due to COVID-19. Cancer medicine journal. 2021 Aug 1;4(2):44-47. Epub 2020 Jun 3. PMID: 32601624
- Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK. Sorafenib for Advanced and Refractory Desmoid Tumors. The New England journal of medicine. 2018 Dec 20;379(25):2417-2428. PMID: 30575484
- Kimmick GG, Major B, Clapp J, Sloan J, Pitcher B, Ballman K, Barginear M, Freedman RA, Artz A, Klepin HD, Lafky JM, Hopkins J, Winer E, Hudis C, Muss H, Cohen H, Jatoi A, Hurria A, Mandelblatt J. Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast cancer research and treatment. 2017 Jun;163(2):391-398. Epub 2017 Mar 10. PMID: 28283904
- Bhatnagar B, Kohlschmidt J, Mrózek K, Zhao Q, Fisher JL, Nicolet D, Walker CJ, Mims AS, Oakes C, Giacopelli B, Orwick S, Boateng I, Blachly JS, Maharry SE, Carroll AJ, Powell BL, Kolitz JE, Stone RM, Byrd JC, Paskett ED, de la Chapelle A, Garzon R, Eisfeld AK. Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia. Cancer discovery. 2021 Mar;11(3):626-637. Epub 2020 Dec 4. PMID: 33277314
- Skolnick A, Schulman RC, Galindo RJ, Mechanick JI. THE ENDOCRINOPATHIES OF MALE ANOREXIA NERVOSA: CASE SERIES. AACE clinical case reports. 2016 Fall;2(4):e351-e357. PMID: 28868357
- Nieto MJ, Hedjar A, Locke M, Caro J, Saif MW. Analysis of Updates in Multiple Myeloma Treatment and Management. Journal of clinical haematology. 2023;4(1):35-42. PMID: 38009096
- Tchelebi LT, Segovia D, Smith K, Shi Q, Fitzgerald TJ, Chuong MD, Zemla TJ, O'Reilly EM, Meyerhardt JA, Koay EJ, Lowenstein J, Shergill A, Katz MHG, Herman JM. Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas. International journal of radiation oncology, biology, physics. 2024 Sep 1;120(1):111-119. Epub 2024 Mar 15. PMID: 38492812
- Goyal SP, Vojnic M, Yang JI, Jose J, Newman E, Saif MW. Neoadjuvant Therapy (NAT) in Localized Pancreatic Cancer: Should We Do It and What Should We Do? Journal of cellular signaling. 2021;2(1):80-84. PMID: 34355216
- Ghaly M, Gogineni E, Herman J, Saif MW. New Potential Options for SBRT in Pancreatic Cancer. Cancer medicine journal. 2021 Mar;4(Suppl 3):41-50. Epub 2021 Feb 18. PMID: 34355218
- Bhatnagar B, Blachly JS, Kohlschmidt J, Eisfeld AK, Volinia S, Nicolet D, Carroll AJ, Block AW, Kolitz JE, Stone RM, Mrózek K, Byrd JC, Bloomfield CD. Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3). Leukemia. 2016 Jul;30(7):1586-9. Epub 2015 Dec 16. PMID: 26669971
- Chi J, Chung SY, Prasad S, Saif MW. The Role of Olaparib in Metastatic Pancreatic Cancer. Cancer medicine journal. 2021 Dec;4(3):89-91. Epub 2021 May 11. PMID: 34151318
- Delahanty LM, Wadden TA, Goodwin PJ, Alfano CM, Thomson CA, Irwin ML, Neuhouser ML, Crane TE, Frank E, Spears PA, Gillis BP, Hershman DL, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hudis C, Winer EP, A Carey L, Partridge AH, Ligibel JA. The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity (Silver Spring, Md.). 2022 Jan;30(1):28-38. PMID: 34932888
- Bhatnagar B, Kohlschmidt J, Orwick SJ, Buelow DR, Fobare S, Oakes CC, Kolitz JE, Uy G, Stock W, Powell BL, Nicolet D, Hertlein EK, Mrózek K, Blachly JS, Eisfeld AK, Baker SD, Byrd JC. Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood advances. 2023 Aug 22;7(16):4671-4675. PMID: 37603350
- Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-oncology. 2016 Apr;18(4):565-74. Epub 2015 Oct 22. PMID: 26493095
- Hitchcock KE, Miller ED, Shi Q, Dixon JG, Gholami S, White SB, Wu C, Goulet CC, George M, Jee KW, Wright CL, Yaeger R, Shergill A, Hong TS, George TJ, O'Reilly EM, Meyerhardt JA, Romesser PB. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). BMC cancer. 2024 Feb 13;24(1):201. PMID: 38350888
- Patel SP, Othus M, Chen Y, Wright GP Jr, Yost KJ, Hyngstrom JR, Hu-Lieskovan S, Lao CD, Fecher LA, Truong TG, Eisenstein JL, Chandra S, Sosman JA, Kendra KL, Wu RC, Devoe CE, Deutsch GB, Hegde A, Khalil M, Mangla A, Reese AM, Ross MI, Poklepovic AS, Phan GQ, Onitilo AA, Yasar DG, Powers BC, Doolittle GC, In GK, Kokot N, Gibney GT, Atkins MB, Shaheen M, Warneke JA, Ikeguchi A, Najera JE, Chmielowski B, Crompton JG, Floyd JD, Hsueh E, Margolin KA, Chow WA, Grossmann KF, Dietrich E, Prieto VG, Lowe MC, Buchbinder EI, Kirkwood JM, Korde L, Moon J, Sharon E, Sondak VK, Ribas A. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. The New England journal of medicine. 2023 Mar 2;388(9):813-823. PMID: 36856617
- Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. MicroRNA expression in cytogenetically normal acute myeloid leukemia. The New England journal of medicine. 2008 May 1;358(18):1919-28. PMID: 18450603
- Galindo RJ, Romao I, Valsamis A, Weinerman S, Harris YT. Hypercalcemia of Malignancy and Colorectal Cancer. World journal of oncology. 2016 Feb;7(1):5-12. PMID: 26998187
- Basch E, Dueck AC, Rogak LJ, Minasian LM, Kelly WK, O'Mara AM, Denicoff AM, Seisler D, Atherton PJ, Paskett E, Carey L, Dickler M, Heist RS, Himelstein A, Rugo HS, Sikov WM, Socinski MA, Venook AP, Weckstein DJ, Lake DE, Biggs DD, Freedman RA, Kuzma C, Kirshner JJ, Schrag D. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials. JAMA oncology. 2017 Aug 1;3(8):1043-1050. PMID: 28208174
- Eisfeld AK, Kohlschmidt J, Mrózek K, Blachly JS, Walker CJ, Nicolet D, Orwick S, Maharry SE, Carroll AJ, Stone RM, de la Chapelle A, Wang ES, Kolitz JE, Powell BL, Byrd JC, Bloomfield CD. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies. Leukemia. 2018 Jun;32(6):1338-1348. Epub 2018 Feb 25. PMID: 29563537
- Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). The oncologist. 2019 Jun;24(6):e284-e291. Epub 2019 Apr 11. PMID: 30975921
- Beumer JH, Owzar K, Lewis LD, Jiang C, Holleran JL, Christner SM, Blum W, Devine S, Kolitz JE, Linker C, Vij R, Alyea EP, Larson RA, Ratain MJ, Egorin MJ. Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer chemotherapy and pharmacology. 2014 Nov;74(5):927-38. Epub 2014 Aug 28. PMID: 25163570
- Eisfeld AK, Kohlschmidt J, Mims A, Nicolet D, Walker CJ, Blachly JS, Carroll AJ, Papaioannou D, Kolitz JE, Powell BE, Stone RM, de la Chapelle A, Byrd JC, Mrózek K, Bloomfield CD. Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years. Leukemia. 2020 Dec;34(12):3215-3227. Epub 2020 May 27. PMID: 32461631
- Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi A. Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101. The oncologist. 2019 May;24(5):617-623. Epub 2018 Nov 8. PMID: 30409792
- Snyder RA, Dueck AC, Fruth B, Shi Q, Hubbard JM, Herman JM, O'Reilly EM, Katz MHG. Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501). Annals of surgery. 2023 Oct 1;278(4):598-608. Epub 2023 Jun 19. PMID: 37334719
- Zent CS, Victoria Wang X, Ketterling RP, Hanson CA, Libby EN, Barrientos JC, Call TG, Chang JE, Liu JJ, Calvo AR, Lazarus HM, Rowe JM, Luger SM, Litzow MR, Tallman MS. A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). American journal of hematology. 2016 Mar;91(3):308-12. Epub 2016 Feb 9. PMID: 26662208
- Saif MW. From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review. JOP : Journal of the pancreas. 2021;22(3):70-79. Epub 2021 May 31. PMID: 34483790
- Ozga M, Nicolet D, Mrózek K, Yilmaz AS, Kohlschmidt J, Larkin KT, Blachly JS, Oakes CC, Buss J, Walker CJ, Orwick S, Jurinovic V, Rothenberg-Thurley M, Dufour A, Schneider S, Sauerland MC, Görlich D, Krug U, Berdel WE, Woermann BJ, Hiddemann W, Braess J, Subklewe M, Spiekermann K, Carroll AJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Uy GL, Stock W, Metzeler KH, Grimes HL, Byrd JC, Salomonis N, Herold T, Mims AS, Eisfeld AK. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). Leukemia. 2024 Jan;38(1):45-57. Epub 2023 Nov 28. PMID: 38017103
- Snyder RA, Zemla TJ, Shi Q, Segovia D, Ahmad SA, O'Reilly EM, Herman JM, Katz MHG. Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501). Annals of surgical oncology. 2024 Oct;31(10):7033-7042. Epub 2024 Jul 15. PMID: 39008208
- Budman DR, Tai J, Calabro A, John V. The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines. Investigational new drugs. 2011 Dec;29(6):1224-9. Epub 2010 Jun 9. PMID: 20533074
- Runcie K, Budman DR, John V, Seetharamu N. Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Molecular medicine (Cambridge, Mass.). 2018 Sep 24;24(1):50. PMID: 30249178
- Warner-Cohen J, Jose J, Saif MW. Years of Fight against Pancreatic Cancer by RGB: Lessons to be Learnt. Cancer medicine journal. 2020 Dec;3(Suppl 2):7-8. Epub 2020 Nov 19. PMID: 33634269
- Larkin KT, Nicolet D, Kelly BJ, Mrózek K, LaHaye S, Miller KE, Wijeratne S, Wheeler G, Kohlschmidt J, Blachly JS, Mims AS, Walker CJ, Oakes CC, Orwick S, Boateng I, Buss J, Heyrosa A, Desai H, Carroll AJ, Blum W, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Stone RM, Paskett ED, Byrd JC, Mardis ER, Eisfeld AK. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. Blood advances. 2022 Oct 11;6(19):5570-5581. PMID: 35788257
- Mrózek K, Kohlschmidt J, Blachly JS, Nicolet D, Carroll AJ, Archer KJ, Mims AS, Larkin KT, Orwick S, Oakes CC, Kolitz JE, Powell BL, Blum WG, Marcucci G, Baer MR, Uy GL, Stock W, Byrd JC, Eisfeld AK. Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia. 2023 Apr;37(4):788-798. Epub 2023 Feb 23. PMID: 36823396
- Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-oncology. 2015 Oct;17(10):1393-401. Epub 2015 May 12. PMID: 25972454
- Marcucci G, Geyer S, Laumann K, Zhao W, Bucci D, Uy GL, Blum W, Eisfeld AK, Pardee TS, Wang ES, Stock W, Kolitz JE, Kohlschmidt J, Mrózek K, Bloomfield CD, Stone RM, Larson RA. Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801. Blood advances. 2020 Feb 25;4(4):696-705. PMID: 32092139
- Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR Jr, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA. 2017 Jan 3;317(1):48-58. PMID: 28030702
- Saif MW. Challenges to Treat Cancer Patients During COVID-19 Pandemic. Annals of King Edward Medical University. 2020 Jun 23;26(Suppl 1):100-103. Epub 2020 Jul 9. PMID: 33194225
- Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M, Westervelt P, Marcucci G, DeAngelo DJ, Vardiman JW, McDonnell D, Mrózek K, Bloomfield CD, Larson RA. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer. 2013 Jan 1;119(1):90-8. Epub 2012 Jun 28. PMID: 22744771
- Kolitz JE, George SL, Benson DM Jr, Maharry K, Marcucci G, Vij R, Powell BL, Allen SL, Deangelo DJ, Shea TC, Stock W, Bakan CE, Hars V, Hoke E, Bloomfield CD, Caligiuri MA, Larson RA, Alliance for Clinical Trials in Oncology. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. Cancer. 2014 Apr 1;120(7):1010-7. Epub 2013 Dec 31. PMID: 24382782
- Uy GL, Mandrekar SJ, Laumann K, Marcucci G, Zhao W, Levis MJ, Klepin HD, Baer MR, Powell BL, Westervelt P, DeAngelo DJ, Stock W, Sanford B, Blum WG, Bloomfield CD, Stone RM, Larson RA. A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001. Blood advances. 2017 Jan 24;1(5):331-340. PMID: 29034366
- Budman DR, Calabro A, Rosen L, Lesser M. Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system. Anti-cancer drugs. 2012 Mar;23(3):272-9. PMID: 23427335
- Nieto MJ, Li Z, Rehman H, Saif MW. Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin's Lymphoma: An Analysis of the SEER Data 1997-2015. Journal of clinical haematology. 2021;2(1):5-13. PMID: 33834180
- Rebechi M, Kohlschmidt J, Mrózek K, Nicolet D, Mims AS, Blachly JS, Orwick S, Larkin KT, Oakes CC, Hantel A, Carroll AJ, Blum WG, Powell BL, Uy GL, Stone RM, Larson RA, Byrd JC, Paskett ED, Plascak JJ, Eisfeld AK. Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances. 2023 Aug 8;7(15):4019-4023. PMID: 37196637
- Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, George SL, Larson RA, Stone RM. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. American journal of hematology. 2016 Feb;91(2):199-204. Epub 2015 Nov 26. PMID: 26526191
- Phillips KA, Regan MM, Ribi K, Francis PA, Puglisi F, Bellet M, Spazzapan S, Karlsson P, Budman DR, Zaman K, Abdi EA, Domchek SM, Feng Y, Price KN, Coates AS, Gelber RD, Maruff P, Boyle F, Forbes JF, Ahles T, Fleming GF, Bernhard J. Adjuvant ovarian function suppression and cognitive function in women with breast cancer. British journal of cancer. 2016 Apr 26;114(9):956-64. Epub 2016 Apr 19. PMID: 27092785
- Chi J, Chitty D, Lee M, Hakim N, Lakhani S, Rajdev L, Zhu X, Saif MW. COVID-19 Clinical Research. Journal of cellular signaling. 2020 Jun;1(2):23-30. Epub 2020 May 5. PMID: 32607505
- Neumann M, Murphy N, Seetharamu N. The Evolving Role of PD-L1 Inhibition in Non-Small Cell Lung Cancer: A Review of Durvalumab and Avelumab. Cancer medicine journal. 2022 Apr;5(1):31-45. Epub 2021 Dec 7. PMID: 35253011
- Fobare S, Kohlschmidt J, Ozer HG, Mrózek K, Nicolet D, Mims AS, Garzon R, Blachly JS, Orwick S, Carroll AJ, Stone RM, Wang ES, Kolitz JE, Powell BL, Oakes CC, Eisfeld AK, Hertlein E, Byrd JC. Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia. Blood advances. 2022 Mar 8;6(5):1371-1380. PMID: 34847232
- Nano O, Nieto MJ, Saif MW, Tarabichi M. Retrospective Analysis of Patients with Gynecological Uterine Sarcomas: Leiomyosarcomas and other Histological Subtypes at a Single Institution from 1996 to 2015. Cancer medicine journal. 2020 Dec;3(Suppl 2):30-37. Epub 2020 Dec 7. PMID: 33634270
- Saif MW. Outstanding Outcome of Pancreatic Cancer: What Lessons Do We Learn. Pancreas (Fairfax, Va.). 2020 Feb;4. Epub 2020 Feb 12. PMID: 32685869
- Newman J, Seetharamu N, Saif MW. Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors. Cancer medicine journal. 2020 Dec;3(Suppl 2):17-21. Epub 2020 Nov 19. PMID: 33377136
- Godara A, Kumar A, Miller KB, Saif MW. Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of Literature. Cancer medicine journal. 2021 Aug 1;4(2):52-59. Epub 2020 Jun 11. PMID: 32685937
- Baig MZ, Filkins A, Khan M, Saif MW, Aziz H. Survival Benefits and Disparities in Adjuvant Radiation Therapy for Patients with Pancreatic Cancer. JOP : Journal of the pancreas. 2021;22(2):36-41. Epub 2021 Mar 30. PMID: 34354555
- Flores S, Kurian N, Yohannan A, Persaud C, Saif MW. Consequences of the COVID-19 Pandemic on Cancer Clinical Trials. Cancer medicine journal. 2021 Apr 1;4(1):38-43. Epub 2020 Jun 3. PMID: 32601623
- Aziz H, Hanna K, Saif MW, Rauf MA, Genyk Y, Sheikh MR. Hepatectomy for Breast Cancer Metastasis and Sarcoma are more likely to have Adverse Outcomes than Hepatectomy for Primary Hepatocellular Cancer or for Colorectal Metastasis. Cancer medicine journal. 2020 Nov;3(Suppl 1):6-12. Epub 2020 Jul 23. PMID: 33196059